Substituted
1,1,1-trifluoro-3-[(benzyl)-(pyrimidin-2-yl)-amino]-propan-2-ol
compounds, pharmaceutical compositions containing such compounds and the
use of such compounds to elevate certain plasma lipid levels, including
high density lipoprotein-cholesterol and to lower certain other plasma
lipid levels, such as LDL-cholesterol and triglycerides and accordingly
to treat diseases which are exacerbated by low levels of HDL cholesterol
and/or high levels of LDL-cholesterol and triglycerides, such as
atherosclerosis and cardiovascular diseases in some mammals, including
humans.
##STR00001##